AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Active Biotech

Major Shareholding Notification Nov 14, 2023

3133_iss_2023-11-14_cf12e1ff-e53c-4011-a339-3aa601e19ce3.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Active Biotech AB (publ)

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument Aktier
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 13/11/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 14,944,044
Directly held voting rights 0
Indirectly held voting rights 14,944,044
Percentage
Directly held shares 5.63618 %
Directly held voting rights 0 %
Indirectly held voting rights 5.63618 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.63618 % 14,944,044
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.63618 % 14,944,044

Group total holdings

Voting rights 14,944,044 Percentage of voting rights 5.63618

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har överskridits på av retur av utlånade aktier.

Published

14/11/2023 14:12

Contact

Name Marie Andersson

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.